10 / 64
CARDIOVASCULAR JOURNAL OF AFRICA • Volume 31, No 6, November/December 2020
290
AFRICA
of thrombus and prevents the development of PTS within three
months when used for the management of lower-extremity DVT.
Moreover, the safety of PMT with low-dose urokinase was
highly satisfactory as none of the subjects enrolled in this study
experienced either intracranial bleeding or pulmonary embolism.
Nevertheless, further studies with longer follow up are needed to
address the role of accelerated PMT with low-dose urokinase in
patients with lower-extremity DVT.
References
1.
Robert-Ebadi H, Righini M. Management of distal deep vein thrombo-
sis.
Thromb Res
2017;
149
: 48–55.
2.
Nordstrom M, Lindblad B, Bergqvist D, Kjellstrom T. A prospective
study of the incidence of deep-vein thrombosis within a defined urban
population.
J Intern Med
1992;
232
: 155–160.
3.
Kearon C, Julian JA, Newman TE, Ginsberg JS. Noninvasive diagnosis
of deep venous thrombosis. McMaster Diagnostic Imaging Practice
Guidelines Initiative.
Ann Intern Med
1998;
128
: 663–677.
4.
Strijkers RH, de Wolf MA, Wittens CH. Risk factors of postthrom-
botic syndrome before and after deep venous thrombosis treatment.
Phlebology
2017;
32
: 384–389.
5.
Kahn SR. The post-thrombotic syndrome: progress and pitfalls.
Br J
Haematol
2006;
134
: 357–365.
6.
Stone J, Hangge P, Albadawi H,
et al
. Deep vein thrombosis: pathogen-
esis, diagnosis, and medical management.
Cardiovasc Diagn Ther
2017;
7
: S276–284.
7.
Miller DJ, Simpson JR, Silver B. Safety of thrombolysis in acute ischem-
ic stroke: a review of complications, risk factors, and newer technologies.
Neurohospitalist
2011;
1
: 138–147.
8.
Vedantham S, Grassi CJ, Ferral H,
et al.
Reporting standards for endo-
vascular treatment of lower extremity deep vein thrombosis.
J Vasc
Interv Radiol
2006;
17
: 417–434.
9.
Dasari TW, Pappy R, Hennebry TA. Pharmacomechanical thromboly-
sis of acute and chronic symptomatic deep vein thrombosis: a systematic
review of literature.
Angiology
2012;
63
: 138–145.
10. Holbrook A, Schulman S, Witt DM,
et al
. Evidence-based management
of anticoagulant therapy. Antithrombotic Therapy and Prevention of
Thrombosis. 9th edn. American College of Chest Physicians Evidence-
Based Clinical Practice Guidelines.
Chest
2012;
141
: e152S–e184S.
11. Meissner MH, Gloviczki P, Comerota AJ,
et al
. Early thrombus removal
strategies for acute deep venous thrombosis: clinical practice guidelines
of the Society for Vascular Surgery and the American Venous Forum.
J
Vasc Surg
2012;
55
: 1449–1462.
12. Baldwin MJ, Moore HM, Rudarakanchana N,
et al
. Post-thrombotic
syndrome: a clinical review.
J Thromb Haemost
2013;
11
: 795–805.
13. Fleck D, Albadawi H, Shamoun F,
et al
. Catheter-directed thrombolysis
of deep vein thrombosis: literature review and practice considerations.
Cardiovasc Diagn Ther
2017;
7
: S228–237.
14. Goldhaber SZ, Meyerovitz MF, Green D,
et al.
Randomized controlled
trial of tissue plasminogen activator in proximal deep venous thrombo-
sis.
Am J Med
1990;
88
: 235–240.
15. Turpie AG, Levine MN, Hirsh J,
et al.
Tissue plasminogen activator
(rt-PA) vs heparin in deep vein thrombosis. Results of a randomized
trial.
Chest
1990;
97
: 172s–175s.
16. Goldhaber SZ, Polak JF, Feldstein ML,
et al
. Efficacy and safety of
repeated boluses of urokinase in the treatment of deep venous throm-
bosis.
Am J Cardiol
1994;
73
: 75–79.
17. Janssen MC, Wollersheim H, Schultze-Kool LJ, Thien T. Local and
systemic thrombolytic therapy for acute deep venous thrombosis.
Neth
J Med
2005;
63
: 81–90.
18. Riess H, Loew A. Behandlung der tiefen Venenthrombose.
Hämostaseologie
2000;
20
: 65–69.
19. Theiss W, Wirtzfeld A, Fink U, Maubach P. The success rate of fibrino-
lytic therapy in fresh and old thrombosis of the iliac and femoral veins.
Angiology
1983;
34
: 61–69.
20. Schweizer J, Kirch W, Koch R,
et al
. Short- and long-term results after
thrombolytic treatment of deep venous thrombosis.
J Am Coll Cardiol
2000;
36
: 1336–1343.
21. Robertson L, McBride O, Burdess A. Pharmacomechanical thrombec-
tomy for iliofemoral deep vein thrombosis.
Cochrane Database Syst Rev
2016;
11
: Cd011536.
22. Comerota AJ, Throm RC, Mathias SD,
et al
. Catheter-directed throm-
bolysis for iliofemoral deep venous thrombosis improves health-related
quality of life.
J Vasc Surg
2000;
32
: 130–137.
23. Tang T, Chen L, Chen J,
et al
. Pharmacomechanical thrombectomy
versus catheter-directed thrombolysis for ıliofemoral deep vein throm-
bosis: a meta-analysis of clinical trials.
Clin Appl Thromb/Hemost
2019;
25
: 1076029618821190.
24. Marston WA. Results of the ATTRACT trial do not change the
management of acute deep vein thrombosis.
J Vasc Surg Venous
Lymphat Disord
2018;
6
: 5–6.
25. Vedantham S, Sista AK, Klein SJ,
et al
. Quality improvement guide-
lines for the treatment of lower-extremity deep vein thrombosis with
use of endovascular thrombus removal.
J Vasc Interv Radiol
2014;
25
:
1317–1325.